Gemcitabine and carboplatin in carcinoma of unknown primary site (CUP) in elderly patients: Analysis of a phase 2 Adelaide Cancer Trials and Education Collaborative (ACTEC) study

The GC regimen is active in CUP with excellent tolerability and should be considered for elderly patients with CUP.